Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION(2024)

引用 0|浏览0
暂无评分
摘要
This cross-sectional study identified the prevalence of patents on risk evaluation and mitigation strategies and their association with delaying generic competition.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要